KR102648658B1 - Body wash using egg yolk oil with anti-aging effect - Google Patents
Body wash using egg yolk oil with anti-aging effect Download PDFInfo
- Publication number
- KR102648658B1 KR102648658B1 KR1020240001695A KR20240001695A KR102648658B1 KR 102648658 B1 KR102648658 B1 KR 102648658B1 KR 1020240001695 A KR1020240001695 A KR 1020240001695A KR 20240001695 A KR20240001695 A KR 20240001695A KR 102648658 B1 KR102648658 B1 KR 102648658B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- oil
- extract
- body wash
- Prior art date
Links
- 210000002969 egg yolk Anatomy 0.000 title claims abstract description 22
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 21
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 21
- 235000013345 egg yolk Nutrition 0.000 title claims abstract description 21
- 230000003712 anti-aging effect Effects 0.000 title description 13
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 239000000284 extract Substances 0.000 claims description 69
- 239000003921 oil Substances 0.000 claims description 55
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 24
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 24
- 229920001577 copolymer Polymers 0.000 claims description 24
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 24
- 239000008213 purified water Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 22
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 22
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 claims description 18
- 229930003799 tocopherol Natural products 0.000 claims description 18
- 229960001295 tocopherol Drugs 0.000 claims description 18
- 239000011732 tocopherol Substances 0.000 claims description 18
- 235000010384 tocopherol Nutrition 0.000 claims description 18
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 18
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 claims description 16
- 235000005979 Citrus limon Nutrition 0.000 claims description 13
- 244000131522 Citrus pyriformis Species 0.000 claims description 13
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 13
- 229940073499 decyl glucoside Drugs 0.000 claims description 13
- 229940031688 sodium c14-16 olefin sulfonate Drugs 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 13
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 12
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 12
- 235000000484 citronellol Nutrition 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 235000001510 limonene Nutrition 0.000 claims description 12
- 229940087305 limonene Drugs 0.000 claims description 12
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 12
- 230000028327 secretion Effects 0.000 claims description 12
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 11
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 11
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 11
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 11
- 239000005792 Geraniol Substances 0.000 claims description 11
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 11
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 11
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 11
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 11
- 229940113087 geraniol Drugs 0.000 claims description 11
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 11
- 229940051250 hexylene glycol Drugs 0.000 claims description 11
- 239000001509 sodium citrate Substances 0.000 claims description 11
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 11
- 239000010632 citronella oil Substances 0.000 claims description 9
- 229940095068 tetradecene Drugs 0.000 claims description 8
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 6
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 6
- 239000004571 lime Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 241000406668 Loxodonta cyclotis Species 0.000 claims 1
- 240000001439 Opuntia Species 0.000 claims 1
- 229940047648 cocoamphodiacetate Drugs 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 238000003809 water extraction Methods 0.000 description 36
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 25
- 238000002156 mixing Methods 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 244000106264 Opuntia compressa Species 0.000 description 18
- 230000003110 anti-inflammatory effect Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 239000003963 antioxidant agent Substances 0.000 description 14
- 230000003078 antioxidant effect Effects 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 14
- 239000011812 mixed powder Substances 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 13
- 230000003020 moisturizing effect Effects 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 12
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 239000002131 composite material Substances 0.000 description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000003750 conditioning effect Effects 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 244000018633 Prunus armeniaca Species 0.000 description 8
- 235000009827 Prunus armeniaca Nutrition 0.000 description 8
- 238000004108 freeze drying Methods 0.000 description 8
- IQQRAVYLUAZUGX-UHFFFAOYSA-N 1-butyl-3-methylimidazolium Chemical compound CCCCN1C=C[N+](C)=C1 IQQRAVYLUAZUGX-UHFFFAOYSA-N 0.000 description 7
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- -1 methylimidazolium tetrafluoroborate Chemical compound 0.000 description 5
- 239000010773 plant oil Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 241001573881 Corolla Species 0.000 description 4
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- XOGODJOZAUTXDH-UHFFFAOYSA-M (N-methylanilino)methanesulfonate Chemical group CN(CS([O-])(=O)=O)c1ccccc1 XOGODJOZAUTXDH-UHFFFAOYSA-M 0.000 description 3
- 241000219357 Cactaceae Species 0.000 description 3
- 241000202327 Coturnix chinensis Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 230000000774 hypoallergenic effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002608 ionic liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000379194 Abies sibirica Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000208150 Geraniaceae Species 0.000 description 1
- 241000134874 Geraniales Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 244000105059 Geranium thunbergii Species 0.000 description 1
- 235000005491 Geranium thunbergii Nutrition 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000000039 Opuntia compressa Nutrition 0.000 description 1
- 235000006546 Opuntia vulgaris Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000010645 fir oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HGTCGIXAQAYYBS-UHFFFAOYSA-N hexacos-9-ene Chemical compound CCCCCCCCCCCCCCCCC=CCCCCCCCC HGTCGIXAQAYYBS-UHFFFAOYSA-N 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003016 quadriplegic effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Abstract
본 발명은 난황유를 포함하는 바디워시 조성물을 제공한다.The present invention provides a body wash composition containing egg yolk oil.
Description
본 발명은 안티에이징 효과를 가지는 난황유를 사용한 바디워시에 관한 것이다.The present invention relates to a body wash using egg yolk oil, which has an anti-aging effect.
피부는 우리 인체 내에서 외부 환경과 가장 밀접하게 접하고 있는 신체기관으로, 인체 내부를 보호하는 생화학적이고 물리적인 기능을 가지고 있는 아주 중요한 기관이다. 이러한 피부가 체내에 활성산소가 생성되면 활성산소가 세포막을 공격하게 되어 세포가 파괴되고 나아가 주름 등을 형성하는 피부노화가 일어난다. 그러므로 항상 피부가 촉촉한 상태를 유지하게 하고 혈액순환을 원활하게 하여 신체 내에 발생하는 활성산소를 소거하여 세포막을 보호하고, 나아가 발한작용의 활성화로 체내 세포에 축적된 모든 독소와 노폐물을 배출시킴으로써 피부의 노화를 지연시킴은 물론 이미 손상 받은 세포는 활발한 신진대사에 의해 재 활성화시켜서 세포를 증식시킬 필요가 있다.The skin is the organ in our human body that is most closely in contact with the external environment, and is a very important organ that has biochemical and physical functions to protect the inside of the human body. When active oxygen is generated in the skin, the oxygen attacks the cell membrane, destroying the cells and further causing skin aging, including the formation of wrinkles. Therefore, it always keeps the skin moist and promotes blood circulation to protect the cell membrane by scavenging free radicals generated in the body. Furthermore, by activating sweating, all toxins and waste accumulated in the body's cells are discharged, thereby improving the skin's health. In addition to delaying aging, it is necessary to proliferate cells by reactivating already damaged cells through active metabolism.
바디워시와 같은 개인 케어 조성물 제품이 미국에서 그리고 전 세계적으로 점점 인기가 있어지고 있다. 바람직한 바디워시 조성물은 다수의 기준을 충족시켜야 한다. 예를 들어, 소비자가 만족스러워하기 위해서는 바디워시 조성물은 우수한세정 특성을 나타내야 하며, 우수한 거품 발생 특징을 나타내야 하고, 피부에 대하여 저자극성이어야 하며, 바람직하게는 심지어 피부에 컨디셔닝 효과도 제공하여야 한다. Personal care composition products such as body wash are becoming increasingly popular in the United States and globally. A desirable body wash composition must meet a number of criteria. For example, to be satisfactory to consumers, body wash compositions must exhibit good cleansing properties, exhibit good lathering characteristics, be hypoallergenic to the skin, and preferably even provide a conditioning effect to the skin.
피부 컨디셔닝 효과를 제공하고자 하는 바디워시 조성물이 공지되어 있다. 이러한 조성물 중 다수는 거품 발생 계면활성제와 조합된 유화된 컨디셔닝 오일 또는 기타 유사한 물질을 함유하는 수성 시스템이다. 이러한 제품은 컨디셔닝 및 세정효과 모두를 제공하지만 사용 동안 충분한 양의 피부 컨디셔닝제를 피부에 침착시키는 제품을 제형화하는 것은 많은 경우에 어렵다. 세정 계면활성제에 의한 피부 컨디셔닝제의 유화와 대항하기 위하여, 다량의 피부 컨디셔닝제가 조성물에 첨가된다. 그러나, 이에 의해 상기 세정 및 컨디셔닝 제품과 관련된 다른 문제가 생기게 된다. 침착을 증가시키기 위하여 피부컨디셔닝제의 수준을 상승시키는 것은 제품의 거품 성능 및 안정성에 부정적인 영향을 준다. 따라서, 거품 수명이 증가되고 거품 발생 특징이 개선된 세정성과, 피부에 대한 효과, 예를 들어 비단결 같은 피부 감촉, 개선된 부드러운 피부 감촉 및 개선된 매끄러운 피부 감촉을 제공하며 안정한 저자극성이고 안티에이징 효과를 나타내는 바디워시 조성물에 대한 필요성이 여전히 남아있다.Body wash compositions intended to provide a skin conditioning effect are known. Many of these compositions are aqueous systems containing emulsified conditioning oils or other similar substances in combination with foaming surfactants. Although these products provide both conditioning and cleansing benefits, it is often difficult to formulate a product that deposits a sufficient amount of skin conditioning agent onto the skin during use. To combat emulsification of the skin conditioning agent by the cleansing surfactant, a large amount of skin conditioning agent is added to the composition. However, this creates other problems associated with these cleaning and conditioning products. Increasing the level of skin conditioning agents to increase deposition has a negative impact on the foam performance and stability of the product. Therefore, the foam life is increased and the foaming characteristics provide improved cleansing and effects on the skin, such as silky skin feel, improved soft skin feel and improved smooth skin feel, as well as a stable, hypoallergenic and anti-aging effect. There still remains a need for body wash compositions that represent.
본 발명은 상기와 같은 문제점을 해결하기 위해 안출된 것으로서, 본 발명의 목적은 안티에이징 효과를 가지는 바디워시 조성물을 제공하는 것이다.The present invention was devised to solve the above problems, and the purpose of the present invention is to provide a body wash composition having an anti-aging effect.
본 발명의 과제는 이상에서 언급한 과제들로 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.The object of the present invention is not limited to the problems mentioned above, and other problems not mentioned will be clearly understood by those skilled in the art from the description below.
상기 목적을 달성하기 위하여 본 발명은In order to achieve the above object, the present invention
난황유를 포함하는 바디워시 조성물을 제공한다.A body wash composition containing egg yolk oil is provided.
또한, 상기 바디워시 조성물은 난황유 0.1-0.3 중량부, 이질풀추출물, 구멍갈파래추출물 및 천년초추출물이 1:1:1의 중량비율로 혼합된 복합추출물 3-7 중량부, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부, 데실글루코사이드 2-4 중량부, 글리세린 0.9-1.1 중량부, 아크릴레이트코폴리머 0.09-0.11 중량부, 시트릭애씨드 0.09-0.11 중량부, 헥실렌글라이콜 0.09-0.11 중량부, C12-13알케스-9 0.09-0.11 중량부, 코코-베타인 0.09-0.11 중량부, 테트라데센 0.09-0.11 중량부, 하이드록시아세토페논 0.4-0.6 중량부, 헥사데센 0.09-0.11 중량부, 스타이렌/아크릴레이트코폴리머 0.4-0.6 중량부, 다이프로필렌글라이콜 0.2-0.4 중량부, 에틸헥실글리세린 0.1-0.3 중량부, 1,2-헥산다이올 0.1-0.3 중량부, 다이소듐이디티에이 0.04-0.06 중량부, 소듐시트레이트 0.00009-0.00011 중량부, 토코페롤 0.00009-0.00011 중량부, 레몬껍질오일 0.09-0.11 중량부, 분비나무오일 0.09-0.11 중량부, 라임전초오일 0.09-0.11 중량부, 시트로넬라오일 0.09-0.11 중량부, 리모넨 0.3-0.5 중량부, 제라니올 0.3-0.5 중량부, 시트로넬올 0.3-0.5 중량부 및 정제수 80.2497-80.2499 중량부를 포함하는 것을 특징으로 한다.In addition, the body wash composition includes 0.1-0.3 parts by weight of egg yolk oil, 3-7 parts by weight of a complex extract of Cranium chinensis extract, Corolla extract, and Prickly pear extract mixed in a weight ratio of 1:1:1, and sodium C14-16 olefin sulfonate. 4-5 parts by weight, disodium cocoamphodiacetate 3-5 parts by weight, sodium chloride 2-4 parts by weight, decyl glucoside 2-4 parts by weight, glycerin 0.9-1.1 parts by weight, acrylate copolymer 0.09-0.11 parts by weight , citric acid 0.09-0.11 parts by weight, hexylene glycol 0.09-0.11 parts by weight, C12-13 Alkes-9 0.09-0.11 parts by weight, coco-betaine 0.09-0.11 parts by weight, tetradecene 0.09-0.11 parts by weight. parts, 0.4-0.6 parts by weight of hydroxyacetophenone, 0.09-0.11 parts by weight of hexadecene, 0.4-0.6 parts by weight of styrene/acrylate copolymer, 0.2-0.4 parts by weight of dipropylene glycol, 0.1-0.3 parts by weight of ethylhexylglycerin. parts by weight, 1,2-hexanediol 0.1-0.3 parts by weight, disodium EDTA 0.04-0.06 parts by weight, sodium citrate 0.00009-0.00011 parts by weight, tocopherol 0.00009-0.00011 parts by weight, lemon peel oil 0.09-0.11 parts by weight parts, secretion tree oil 0.09-0.11 parts by weight, lime starch oil 0.09-0.11 parts by weight, citronella oil 0.09-0.11 parts by weight, limonene 0.3-0.5 parts by weight, geraniol 0.3-0.5 parts by weight, citronellol 0.3 -0.5 parts by weight and 80.2497-80.2499 parts by weight of purified water.
또한, 본 발명은In addition, the present invention
이질풀잎, 구멍갈파래 및 천년초를 세척하고, 48-52℃의 온도에서 2-4시간 동안 건조하는 단계; 건조한 이질풀잎, 구멍갈파래 및 천년초를 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하는 단계; 상기 혼합분말 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 118-122℃의 온도에서 5-7시간 동안 1차 열수추출을 수행하는 단계; 1차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 1차 추출물을 제조하는 단계; 1차 열수추출 후 여과지로 여과한 다음 남은 고형물 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 여기에 토코페롤 0.8-1.2 중량부 및 [BMIM][BF4](1-butyl-3-methylimidazolium tetrafluoroborate)를 0.8-1.2 중량부를 첨가한 후 교반하면서 88-92℃의 온도에서 10-14시간 동안 2차 열수추출을 수행하는 단계; 2차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 2차 추출물을 제조하는 단계; 및 상기 1차 추출물 및 2차 추출물을 혼합하는 단계;를 포함하는 복합추출물을 제조하는 단계; 및Washing the Chinese herbaceous leaves, Chinese apricots and prickly prickly pear and drying them at a temperature of 48-52°C for 2-4 hours; Preparing a mixed powder by grinding dried Chinese herbaceous leaves, Chinese apricots, and Chinese prickly pear and mixing them at a weight ratio of 1:1:1; Mixing 8-12 parts by weight of the mixed powder and 88-92 parts by weight of purified water and performing primary hot water extraction at a temperature of 118-122°C for 5-7 hours; After primary hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a primary extract; After the first hot water extraction and filtering with filter paper, 8-12 parts by weight of the remaining solids and 88-92 parts by weight of purified water were mixed, and 0.8-1.2 parts by weight of tocopherol and [BMIM][BF 4 ](1-butyl-3- Adding 0.8-1.2 parts by weight of methylimidazolium tetrafluoroborate) and performing secondary hot water extraction at a temperature of 88-92°C for 10-14 hours while stirring; After secondary hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a secondary extract; and mixing the primary extract and the secondary extract; preparing a composite extract comprising; and
난황유 0.1-0.3 중량부, 상기 복합추출물 3-7 중량부, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부, 데실글루코사이드 2-4 중량부, 글리세린 0.9-1.1 중량부, 아크릴레이트코폴리머 0.09-0.11 중량부, 시트릭애씨드 0.09-0.11 중량부, 헥실렌글라이콜 0.09-0.11 중량부, C12-13알케스-9 0.09-0.11 중량부, 코코-베타인 0.09-0.11 중량부, 테트라데센 0.09-0.11 중량부, 하이드록시아세토페논 0.4-0.6 중량부, 헥사데센 0.09-0.11 중량부, 스타이렌/아크릴레이트코폴리머 0.4-0.6 중량부, 다이프로필렌글라이콜 0.2-0.4 중량부, 에틸헥실글리세린 0.1-0.3 중량부, 1,2-헥산다이올 0.1-0.3 중량부, 다이소듐이디티에이 0.04-0.06 중량부, 소듐시트레이트 0.00009-0.00011 중량부, 토코페롤 0.00009-0.00011 중량부, 레몬껍질오일 0.09-0.11 중량부, 분비나무오일 0.09-0.11 중량부, 라임전초오일 0.09-0.11 중량부, 시트로넬라오일 0.09-0.11 중량부, 리모넨 0.3-0.5 중량부, 제라니올 0.3-0.5 중량부, 시트로넬올 0.3-0.5 중량부 및 정제수 80.2497-80.2499 중량부를 혼합하는 단계;를 포함하는 바디워시 조성물의 제조방법을 제공한다.Egg yolk oil 0.1-0.3 parts by weight, 3-7 parts by weight of the above complex extract, 4-5 parts by weight of sodium C14-16 olefin sulfonate, 3-5 parts by weight of disodium cocoamphodiacetate, 2-4 parts by weight of sodium chloride, decyl Glucoside 2-4 parts by weight, glycerin 0.9-1.1 parts by weight, acrylate copolymer 0.09-0.11 parts by weight, citric acid 0.09-0.11 parts by weight, hexylene glycol 0.09-0.11 parts by weight, C12-13 Alkes- 9 0.09-0.11 parts by weight, coco-betaine 0.09-0.11 parts by weight, tetradecene 0.09-0.11 parts by weight, hydroxyacetophenone 0.4-0.6 parts by weight, hexadecene 0.09-0.11 parts by weight, styrene/acrylate copolymer 0.4-0.6 parts by weight, dipropylene glycol 0.2-0.4 parts by weight, ethylhexylglycerin 0.1-0.3 parts by weight, 1,2-hexanediol 0.1-0.3 parts by weight, disodium EDTA 0.04-0.06 parts by weight, Sodium citrate 0.00009-0.00011 parts by weight, tocopherol 0.00009-0.00011 parts by weight, lemon peel oil 0.09-0.11 parts by weight, secretion tree oil 0.09-0.11 parts by weight, lime whole plant oil 0.09-0.11 parts by weight, citronella oil 0.09-0.11 parts by weight, mixing 0.3-0.5 parts by weight of limonene, 0.3-0.5 parts by weight of geraniol, 0.3-0.5 parts by weight of citronellol, and 80.2497-80.2499 parts by weight of purified water; providing a method for producing a body wash composition comprising: .
본 발명에 따른 바디워시 조성물은 항산화 기능성 및 항염 기능성을 가짐으로써 안티에이징 효과를 가진다. 또한, 피부보습력이 우수하고 자극성이 낮다.The body wash composition according to the present invention has an anti-aging effect by having antioxidant and anti-inflammatory functions. In addition, it has excellent skin moisturizing power and low irritation.
이하에서는 다양한 실시예를 보다 상세하게 설명한다. 본 명세서에 기재된 실시예는 다양하게 변형될 수 있다. 특정한 실시예가 상세한 설명에서 자세하게 설명될 수 있다. 그러나 개시된 특정한 실시 예는 다양한 실시예를 쉽게 이해하도록 하기 위한 것일 뿐이다. 따라서 개시된 특정 실시예에 의해 기술적 사상이 제한되는 것은 아니며, 발명의 사상 및 기술 범위에 포함되는 모든 균등물 또는 대체물을 포함하는 것으로 이해되어야 한다.Hereinafter, various embodiments will be described in more detail. The embodiments described herein may be modified in various ways. Specific embodiments may be described in detail in the detailed description. However, the specific embodiments disclosed are only intended to facilitate understanding of the various embodiments. Accordingly, the technical idea is not limited to the specific embodiments disclosed, and should be understood to include all equivalents or substitutes included in the spirit and technical scope of the invention.
1차, 2차, 제1, 제2 등과 같이 서수를 포함하는 용어는 다양한 구성요소들을 설명하는데 사용될 수 있지만, 이러한 구성요소들은 상술한 용어에 의해 한정되지는 않는다. 상술한 용어는 하나의 구성요소를 다른 구성요소로부터 구별하는 목적으로만 사용된다.Terms containing ordinal numbers, such as primary, secondary, first, second, etc., may be used to describe various components, but these components are not limited by the above-mentioned terms. The above-mentioned terms are used only for the purpose of distinguishing one component from another.
본 명세서에서, '포함한다' 또는 '가지다' 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다. 어떤 구성요소가 다른 구성요소에 '연결되어' 있다거나 '접속되어' 있다고 언급된 때에는, 그 다른 구성요소에 직접적으로 연결되어 있거나 또는 접속되어 있을 수도 있지만, 중간에 다른 구성요소가 존재할 수도 있다고 이해되어야 할 것이다. 반면에, 어떤 구성요소가 다른 구성요소에 '직접 연결되어' 있다거나 '직접 접속되어' 있다고 언급된 때에는, 중간에 다른 구성요소가 존재하지 않는 것으로 이해되어야 할 것이다.In this specification, terms such as 'include' or 'have' are intended to designate the presence of features, numbers, steps, operations, components, parts, or combinations thereof described in the specification, but are not intended to indicate the presence of one or more other features. It should be understood that this does not exclude in advance the possibility of the existence or addition of elements, numbers, steps, operations, components, parts, or combinations thereof. When a component is said to be 'connected' or 'connected' to another component, it is understood that it may be directly connected or connected to the other component, but that other components may exist in between. It should be. On the other hand, when a component is mentioned as being 'directly connected' or 'directly connected' to another component, it should be understood that there are no other components in between.
그 밖에도, 본 발명을 설명함에 있어서, 관련된 공지 기능 혹은 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우, 그에 대한 상세한 설명은 축약하거나 생략한다.In addition, when describing the present invention, if it is determined that a detailed description of a related known function or configuration may unnecessarily obscure the gist of the present invention, the detailed description thereof is abbreviated or omitted.
본 발명은This invention
난황유를 포함하는 바디워시 조성물을 제공한다.A body wash composition containing egg yolk oil is provided.
이하, 본 발명에 따른 바디워시 조성물에 대하여 상세히 설명한다.Hereinafter, the body wash composition according to the present invention will be described in detail.
상기 바디워시 조성물은 난황유 0.1-0.3 중량부, 이질풀추출물, 구멍갈파래추출물 및 천년초추출물이 1:1:1의 중량비율로 혼합된 복합추출물 3-7 중량부, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부, 데실글루코사이드 2-4 중량부, 글리세린 0.9-1.1 중량부, 아크릴레이트코폴리머 0.09-0.11 중량부, 시트릭애씨드 0.09-0.11 중량부, 헥실렌글라이콜 0.09-0.11 중량부, C12-13알케스-9 0.09-0.11 중량부, 코코-베타인 0.09-0.11 중량부, 테트라데센 0.09-0.11 중량부, 하이드록시아세토페논 0.4-0.6 중량부, 헥사데센 0.09-0.11 중량부, 스타이렌/아크릴레이트코폴리머 0.4-0.6 중량부, 다이프로필렌글라이콜 0.2-0.4 중량부, 에틸헥실글리세린 0.1-0.3 중량부, 1,2-헥산다이올 0.1-0.3 중량부, 다이소듐이디티에이 0.04-0.06 중량부, 소듐시트레이트 0.00009-0.00011 중량부, 토코페롤 0.00009-0.00011 중량부, 레몬껍질오일 0.09-0.11 중량부, 분비나무오일 0.09-0.11 중량부, 라임전초오일 0.09-0.11 중량부, 시트로넬라오일 0.09-0.11 중량부, 리모넨 0.3-0.5 중량부, 제라니올 0.3-0.5 중량부, 시트로넬올 0.3-0.5 중량부 및 정제수 80.2497-80.2499 중량부를 포함하는 바디워시 조성물.The body wash composition includes 0.1-0.3 parts by weight of egg yolk oil, 3-7 parts by weight of a composite extract of 0.1-0.3 parts by weight of E. chinensis extract, Corolla extract, and Prickly pear extract mixed in a weight ratio of 1:1:1, and 4-4% sodium C14-16 olefin sulfonate. 5 parts by weight, disodium cocoamphodiacetate 3-5 parts by weight, sodium chloride 2-4 parts by weight, decyl glucoside 2-4 parts by weight, glycerin 0.9-1.1 parts by weight, acrylate copolymer 0.09-0.11 parts by weight, sheet Rick acid 0.09-0.11 parts by weight, hexylene glycol 0.09-0.11 parts by weight, C12-13alces-9 0.09-0.11 parts by weight, coco-betaine 0.09-0.11 parts by weight, tetradecene 0.09-0.11 parts by weight, Hydroxyacetophenone 0.4-0.6 parts by weight, hexadecene 0.09-0.11 parts by weight, styrene/acrylate copolymer 0.4-0.6 parts by weight, dipropylene glycol 0.2-0.4 parts by weight, ethylhexylglycerin 0.1-0.3 parts by weight , 1,2-hexanediol 0.1-0.3 parts by weight, disodium EDTA 0.04-0.06 parts by weight, sodium citrate 0.00009-0.00011 parts by weight, tocopherol 0.00009-0.00011 parts by weight, lemon peel oil 0.09-0.11 parts by weight, Secretion tree oil 0.09-0.11 parts by weight, lime starch oil 0.09-0.11 parts by weight, citronella oil 0.09-0.11 parts by weight, limonene 0.3-0.5 parts by weight, geraniol 0.3-0.5 parts by weight, citronellol 0.3-0.5 A body wash composition comprising 80.2497-80.2499 parts by weight of purified water.
상기 바디워시 조성물은 난황유 0.1-0.3 중량부, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부, 데실글루코사이드 2-4 중량부, 글리세린 0.9-1.1 중량부, 아크릴레이트코폴리머 0.09-0.11 중량부, 시트릭애씨드 0.09-0.11 중량부, 헥실렌글라이콜 0.09-0.11 중량부, C12-13알케스-9 0.09-0.11 중량부, 코코-베타인 0.09-0.11 중량부, 테트라데센 0.09-0.11 중량부, 하이드록시아세토페논 0.4-0.6 중량부, 헥사데센 0.09-0.11 중량부, 스타이렌/아크릴레이트코폴리머 0.4-0.6 중량부, 다이프로필렌글라이콜 0.2-0.4 중량부, 에틸헥실글리세린 0.1-0.3 중량부, 1,2-헥산다이올 0.1-0.3 중량부, 다이소듐이디티에이 0.04-0.06 중량부, 소듐시트레이트 0.00009-0.00011 중량부, 토코페롤 0.00009-0.00011 중량부, 레몬껍질오일 0.09-0.11 중량부, 분비나무오일 0.09-0.11 중량부, 라임전초오일 0.09-0.11 중량부, 시트로넬라오일 0.09-0.11 중량부, 리모넨 0.3-0.5 중량부, 제라니올 0.3-0.5 중량부, 시트로넬올 0.3-0.5 중량부 및 정제수 80.2497-80.2499 중량부를 포함하는 것이 바람직하다.The body wash composition includes 0.1-0.3 parts by weight of egg yolk oil, 4-5 parts by weight of sodium C14-16 olefin sulfonate, 3-5 parts by weight of disodium cocoamphodiacetate, 2-4 parts by weight of sodium chloride, and 2-4 parts by weight of decyl glucoside. Parts by weight, glycerin 0.9-1.1 parts by weight, acrylate copolymer 0.09-0.11 parts by weight, citric acid 0.09-0.11 parts by weight, hexylene glycol 0.09-0.11 parts by weight, C12-13Alces-9 0.09-0.11 parts by weight, coco-betaine 0.09-0.11 parts by weight, tetradecene 0.09-0.11 parts by weight, hydroxyacetophenone 0.4-0.6 parts by weight, hexadecene 0.09-0.11 parts by weight, styrene/acrylate copolymer 0.4-0.6 parts by weight parts, dipropylene glycol 0.2-0.4 parts by weight, ethylhexylglycerin 0.1-0.3 parts by weight, 1,2-hexanediol 0.1-0.3 parts by weight, disodium EDTA 0.04-0.06 parts by weight, sodium citrate 0.00009 -0.00011 parts by weight, tocopherol 0.00009-0.00011 parts by weight, lemon peel oil 0.09-0.11 parts by weight, secretion tree oil 0.09-0.11 parts by weight, lime whole plant oil 0.09-0.11 parts by weight, citronella oil 0.09-0.11 parts by weight, limonene It is preferable to include 0.3-0.5 parts by weight, 0.3-0.5 parts by weight of geraniol, 0.3-0.5 parts by weight of citronellol, and 80.2497-80.2499 parts by weight of purified water.
난황유는 조류 알의 난황(노른자)에서 추출된 유상의 추출물이며, 난황유, 계란기름, 계란유 등으로 불리운다. 난황유는 지질, 비타민 A, 비타민 E, 리놀산 등을 함유하는 것으로 알려져 있으며, 지질은 중성지질, 인지질, 스테롤 등으로 구성되는 것으로 알려져 있다. 본 발명에서는 상기 난황유를 바디워시 조성물에 적용한다. 이에 따라 안티에이징 효과가 우수하다.Egg yolk oil is an oily extract extracted from the egg yolk (yolk) of bird eggs, and is called egg yolk oil, egg oil, egg oil, etc. Egg yolk oil is known to contain lipids, vitamin A, vitamin E, and linoleic acid, and lipids are known to be composed of neutral lipids, phospholipids, and sterols. In the present invention, the egg yolk oil is applied to a body wash composition. Accordingly, the anti-aging effect is excellent.
상기 소듐C14-16올레핀설포네이트, 다이소듐코코암포다이아세테이트, 소듐클로라이드 및 데실글루코사이드는 계면활성제로 적용하되, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부 및 데실글루코사이드 2-4 중량부를 혼합하여 적용한다. 이에 따라 상기 바디워시 조성물은 세정력이 우수하며, 저자극성을 나타낸다.The above sodium C14-16 olefin sulfonate, disodium cocoamphodiacetate, sodium chloride and decyl glucoside are used as surfactants, with 4-5 parts by weight of sodium C14-16 olefin sulfonate and 3-5 parts by weight of disodium cocoamphodiacetate. Part by weight, 2-4 parts by weight of sodium chloride and 2-4 parts by weight of decyl glucoside are mixed and applied. Accordingly, the body wash composition has excellent cleaning power and is hypoallergenic.
상기 글리세린은 보습력을 향상시켜 준다.The glycerin improves moisturizing power.
상기 아크릴레이트코폴리머, C12-13알케스-9, 코코-베타인, 스타이렌/아크릴레이트코폴리머는 화장료에 적용되는 일반적인 성분을 적용할 수 있다.The acrylate copolymer, C12-13 Alkes-9, coco-betaine, and styrene/acrylate copolymer can be general ingredients applied to cosmetics.
상기 레몬껍질오일은 레몬의 밝은 노란색 껍질에서 냉압착법으로 추출한 에센셜 오일로, 항산화 기능성, 항염 기능성, 피부보습 기능성을 가진다.The lemon peel oil is an essential oil extracted from the bright yellow peel of a lemon by cold pressing, and has antioxidant, anti-inflammatory, and skin moisturizing properties.
상기 분비나무오일은 시베리아 전나무 오일이라고도 하며, 신선한 혀브 향을 나타내고, 근육 통증 완화에 도움을 준다고 알려져 있으며, 항산화 기능성, 항염 기능성, 피부보습 기능성을 가진다.The secretion tree oil is also called Siberian fir oil, and is known to have a fresh aroma, help relieve muscle pain, and have antioxidant, anti-inflammatory, and skin moisturizing properties.
상기 라임전초오일은 라임전초에서 냉압착법으로 추출한 에센셜 오일로, 항산화 기능성, 항염 기능성, 피부보습 기능성을 가진다.The lime whole plant oil is an essential oil extracted from lime whole plant by cold pressing, and has antioxidant, anti-inflammatory, and skin moisturizing functions.
상기 시트로넬라오일은 마음을 정화시키고, 고양시키는 효과가 있고, 우울증을 해소시키며, 신경안정 효과가 있음이 알려져 있고, 항산화 기능성, 항염 기능성, 피부보습 기능성을 가진다.The citronella oil is known to have a mind-purifying and uplifting effect, relieve depression, and have a nerve stabilizing effect, and has antioxidant, anti-inflammatory, and skin moisturizing properties.
상기 리모넨은 항산화, 항염 기능성 뿐만 아니라 미백 기능성을 가진다.The limonene has antioxidant and anti-inflammatory properties as well as whitening properties.
상기 제라니올은 항균성, 항염증성이 뛰어나다.The geraniol has excellent antibacterial and anti-inflammatory properties.
상기 시트로넬올은 카모마일 식물에서 추출하여 정제하여 얻은 알코올로 피부를 치유하는 성분과 항균, 항염증 성분이 있어 피부 자극 완화, 피부 보습에 효과적이다.The citronellol is an alcohol obtained by extracting and purifying the chamomile plant. It has skin-healing ingredients, antibacterial and anti-inflammatory ingredients, and is effective in relieving skin irritation and moisturizing the skin.
또한, 상기 바디워시 조성물은 이질풀추출물, 구멍갈파래추출물 및 천년초추출물이 1:1:1의 중량비율로 혼합된 복합추출물 3-7 중량부를 포함하는 것이 바람직하고, 4-6 중량부를 포함하는 것이 더욱 바람직하다.In addition, the body wash composition preferably contains 3-7 parts by weight, and more preferably 4-6 parts by weight, of a composite extract in which the E. chinensis extract, Corolla extract, and Prickly prickly pear extract are mixed in a weight ratio of 1:1:1. desirable.
이질풀(Geranium thunbergii Sieb. and Zucc)은 쥐손이풀목(Geraniales) 쥐손이풀속(Geranium LINNE) 쥐손이풀과(Geraniaceae)에 속하는 다년생 초본이다. 쥐손이풀과 식물은 온대지방과 열대지방의 고산지대에 약 250종이 분포하고 한국에 약 16종 분포한다. 이 생약은 한방에서 현초(玄草) 또는 현지초(玄之草)라고 하며 전초를 가을에 재취하여 다듬어서 말린 것을 말한다. 이질풀은 고, 신, 미온의 성미를 나타내며, 거풍제습 및 지사 효능 즉 풍습을 제거시키고 경락을 소통시켜 골격과 근육을 강건하게 하므로 사지마비동통, 관절불리, 타박상 등에 활용되고, 이질과 만성설사복통, 장염에 효과가 있음이 알려져 있다.Geranium thunbergii Sieb. and Zucc is a perennial herb belonging to the order Geraniales, Geranium LINNE, and Geraniaceae. Approximately 250 species of plants in the Arboraceae family are distributed in temperate and tropical alpine regions, and approximately 16 species are distributed in Korea. This herbal medicine is called Hyeoncho (玄草) or Hyangyangcho (玄之草) in Oriental medicine, and refers to the whole plant harvested in the fall, trimmed, and dried. Dysentery exhibits the properties of cold, sour, and cold. It has dehumidifying and anti-diarrheal effects; it removes wind and dampness and strengthens the skeleton and muscles by communicating meridians, so it is used for quadriplegic pain, joint discomfort, bruises, etc., as well as dysentery and chronic diarrhea and abdominal pain. , it is known to be effective for enteritis.
구멍갈파래는 녹조류 갈파랫과에 속하고 길이는 10~50cm이고 얇은 잎 모양으로 녹색을 띈다. 식물체의 기부는 물결모양으로 꾸불꾸불하게 위었지만 위로 갈수록 넓게 펼쳐진다. 식물체의 가장자리는 매끈하며 식물의 표면에서 볼 때 세포는 모서리가 없는 다각형으로 둘씩 짝을 이루고 엽록체는 짝을 이룬 세포의 반대 쪽에 있다. 단면에서 세포는 네모꼴이며 엽록체는 보통 세포의 허리부분에 있고 드물게 식물체의 표면 쪽에 있는 것이 있다.It belongs to the green algae family, and is 10 to 50 cm long and has green, thin leaves. The base of the plant is wavy and curved, but it spreads out wider toward the top. The edges of the plant are smooth, and when viewed from the surface of the plant, the cells are paired in polygons with no edges, and the chloroplasts are on the opposite side of the paired cells. In cross section, the cell is square, and the chloroplast is usually located at the waist of the cell, but rarely is located on the surface of the plant.
천년초(Opintia humifusa, Eastern prickly pear)는 우리나라에 자생하는 오핀티아 속(Opintia sp.) 선인장 중 내륙에서 월동이 가능한 선인장으로, 제주도에 자생하는 선인장인 백년초와 구분된다. 천년초는 줄기의 형태가 손바닥과 비슷하여 손바닥 선인장으로도 불리우며, 천년초에는 페놀성 물질과 플라보노이드, 식이섬유, 비타민 C 칼슘, 무기질 및 아미노산, 복합 다당류 등과 같이 중요한 각종 영양성분을 함유하고 있다. Opintia humifusa (Eastern prickly pear) is a cactus of the genus Opintia (Opintia sp.) native to Korea that can overwinter inland, and is distinguished from prickly pear, a cactus native to Jeju Island. Prickly pear is also called a palm cactus because its stem has a shape similar to that of a palm. It contains various important nutrients such as phenolic substances, flavonoids, dietary fiber, vitamin C, calcium, minerals, amino acids, and complex polysaccharides.
본 발명에서는 이질풀, 구멍갈파래 및 천년초를 이용한 복합추출물을 바디워시 조성물에 적용하고자 하며, 상기 복합추출물을 포함하여 우수한 항산화 기능성 및 항염 기능성을 통한 안티에이징 효과가 우수하다.In the present invention, a complex extract using Crayon chinensis, Longus chinensis, and Prickly pear is applied to a body wash composition, and the complex extract has excellent anti-aging effect through excellent antioxidant and anti-inflammatory functionality.
상기 복합추출물은,The complex extract is,
이질풀잎, 구멍갈파래 및 천년초를 세척하고, 48-52℃의 온도에서 2-4시간 동안 건조하는 단계; 건조한 이질풀잎, 구멍갈파래 및 천년초를 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하는 단계; 상기 혼합분말 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 118-122℃의 온도에서 5-7시간 동안 1차 열수추출을 수행하는 단계; 1차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 1차 추출물을 제조하는 단계; 1차 열수추출 후 여과지로 여과한 다음 남은 고형물 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 여기에 토코페롤 0.8-1.2 중량부 및 [BMIM][BF4](1-butyl-3-methylimidazolium tetrafluoroborate)를 0.8-1.2 중량부를 첨가한 후 교반하면서 88-92℃의 온도에서 10-14시간 동안 2차 열수추출을 수행하는 단계; 2차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 2차 추출물을 제조하는 단계; 및 상기 1차 추출물 및 2차 추출물을 혼합하는 단계;를 수행하여 제조되는 것을 사용하는 것이 바람직하다.Washing the leaves of the Chinese herbaceous plant, the Chinese herbaceous plant, and the Chinese prickly pear and drying them at a temperature of 48-52°C for 2-4 hours; Preparing a mixed powder by grinding dried Chinese herbaceous leaves, Chinese apricots and prickly prickly pear and mixing them at a weight ratio of 1:1:1; Mixing 8-12 parts by weight of the mixed powder and 88-92 parts by weight of purified water and performing primary hot water extraction at a temperature of 118-122°C for 5-7 hours; After the first hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a first extract; After the first hot water extraction and filtering with filter paper, 8-12 parts by weight of the remaining solids and 88-92 parts by weight of purified water were mixed, and 0.8-1.2 parts by weight of tocopherol and [BMIM][BF 4 ](1-butyl-3- Adding 0.8-1.2 parts by weight of methylimidazolium tetrafluoroborate) and performing secondary hot water extraction at a temperature of 88-92°C for 10-14 hours while stirring; After secondary hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a secondary extract; It is preferable to use one prepared by performing the step of mixing the primary extract and the secondary extract.
상기 복합추출물을 제조함에 있어서, 2단계의 열수추출을 적용하되, 1차 열수추출을 통해 추출액 제조와 더불어 전처리 과정을 거친 후, 2차 열수추출을 수행하되, 첨가제로 토코페롤과 이온성액체 중 [BMIM[BF4]를 동시 적용하여 추출성능을 높여 유효성분의 추출효율이 우수하다. 이에 따라 상기 복합추출물을 적용하는 경우 더욱 우수한 항산화 기능성 및 항염 기능성을 통해 안티에이징 효과가 향상된다.In preparing the complex extract, a two-stage hot water extraction is applied, and after a pretreatment process is performed along with the preparation of the extract through the first hot water extraction, a second hot water extraction is performed, and tocopherol and ionic liquid [ The extraction performance is improved by simultaneously applying BMIM[BF 4 ], resulting in excellent extraction efficiency of active ingredients. Accordingly, when the above complex extract is applied, the anti-aging effect is improved through superior antioxidant and anti-inflammatory functionality.
또한, 본 발명은In addition, the present invention
이질풀잎, 구멍갈파래 및 천년초를 세척하고, 48-52℃의 온도에서 2-4시간 동안 건조하는 단계; 건조한 이질풀잎, 구멍갈파래 및 천년초를 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하는 단계; 상기 혼합분말 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 118-122℃의 온도에서 5-7시간 동안 1차 열수추출을 수행하는 단계; 1차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 1차 추출물을 제조하는 단계; 1차 열수추출 후 여과지로 여과한 다음 남은 고형물 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 여기에 토코페롤 0.8-1.2 중량부 및 [BMIM][BF4](1-butyl-3-methylimidazolium tetrafluoroborate)를 0.8-1.2 중량부를 첨가한 후 교반하면서 88-92℃의 온도에서 10-14시간 동안 2차 열수추출을 수행하는 단계; 2차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 2차 추출물을 제조하는 단계; 및 상기 1차 추출물 및 2차 추출물을 혼합하는 단계;를 포함하는 복합추출물을 제조하는 단계; 및Washing the leaves of the Chinese herbaceous plant, the Chinese herbaceous plant, and the Chinese prickly pear and drying them at a temperature of 48-52°C for 2-4 hours; Preparing a mixed powder by grinding dried Chinese herbaceous leaves, Chinese apricots and prickly prickly pear and mixing them at a weight ratio of 1:1:1; Mixing 8-12 parts by weight of the mixed powder and 88-92 parts by weight of purified water and performing primary hot water extraction at a temperature of 118-122°C for 5-7 hours; After the first hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a first extract; After the first hot water extraction and filtering with filter paper, 8-12 parts by weight of the remaining solids and 88-92 parts by weight of purified water were mixed, and 0.8-1.2 parts by weight of tocopherol and [BMIM][BF 4 ](1-butyl-3- Adding 0.8-1.2 parts by weight of methylimidazolium tetrafluoroborate) and performing secondary hot water extraction at a temperature of 88-92°C for 10-14 hours while stirring; After secondary hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a secondary extract; and mixing the primary extract and the secondary extract; preparing a composite extract comprising; and
난황유 0.1-0.3 중량부, 상기 복합추출물 3-7 중량부, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부, 데실글루코사이드 2-4 중량부, 글리세린 0.9-1.1 중량부, 아크릴레이트코폴리머 0.09-0.11 중량부, 시트릭애씨드 0.09-0.11 중량부, 헥실렌글라이콜 0.09-0.11 중량부, C12-13알케스-9 0.09-0.11 중량부, 코코-베타인 0.09-0.11 중량부, 테트라데센 0.09-0.11 중량부, 하이드록시아세토페논 0.4-0.6 중량부, 헥사데센 0.09-0.11 중량부, 스타이렌/아크릴레이트코폴리머 0.4-0.6 중량부, 다이프로필렌글라이콜 0.2-0.4 중량부, 에틸헥실글리세린 0.1-0.3 중량부, 1,2-헥산다이올 0.1-0.3 중량부, 다이소듐이디티에이 0.04-0.06 중량부, 소듐시트레이트 0.00009-0.00011 중량부, 토코페롤 0.00009-0.00011 중량부, 레몬껍질오일 0.09-0.11 중량부, 분비나무오일 0.09-0.11 중량부, 라임전초오일 0.09-0.11 중량부, 시트로넬라오일 0.09-0.11 중량부, 리모넨 0.3-0.5 중량부, 제라니올 0.3-0.5 중량부, 시트로넬올 0.3-0.5 중량부 및 정제수 80.2497-80.2499 중량부를 혼합하는 단계;를 포함하는 바디워시 조성물의 제조방법을 제공한다.Egg yolk oil 0.1-0.3 parts by weight, 3-7 parts by weight of the above complex extract, 4-5 parts by weight of sodium C14-16 olefin sulfonate, 3-5 parts by weight of disodium cocoamphodiacetate, 2-4 parts by weight of sodium chloride, decyl Glucoside 2-4 parts by weight, glycerin 0.9-1.1 parts by weight, acrylate copolymer 0.09-0.11 parts by weight, citric acid 0.09-0.11 parts by weight, hexylene glycol 0.09-0.11 parts by weight, C12-13 Alkes- 9 0.09-0.11 parts by weight, coco-betaine 0.09-0.11 parts by weight, tetradecene 0.09-0.11 parts by weight, hydroxyacetophenone 0.4-0.6 parts by weight, hexadecene 0.09-0.11 parts by weight, styrene/acrylate copolymer 0.4-0.6 parts by weight, dipropylene glycol 0.2-0.4 parts by weight, ethylhexylglycerin 0.1-0.3 parts by weight, 1,2-hexanediol 0.1-0.3 parts by weight, disodium EDTA 0.04-0.06 parts by weight, Sodium citrate 0.00009-0.00011 parts by weight, tocopherol 0.00009-0.00011 parts by weight, lemon peel oil 0.09-0.11 parts by weight, secretion tree oil 0.09-0.11 parts by weight, lime whole plant oil 0.09-0.11 parts by weight, citronella oil 0.09-0.11 parts by weight, mixing 0.3-0.5 parts by weight of limonene, 0.3-0.5 parts by weight of geraniol, 0.3-0.5 parts by weight of citronellol, and 80.2497-80.2499 parts by weight of purified water; providing a method for producing a body wash composition comprising: .
이하, 본 발명에 따른 바디워시 조성물의 제조방법에 대하여 각 단계별로 상세히 설명한다.Hereinafter, the manufacturing method of the body wash composition according to the present invention will be described in detail in each step.
먼저, 본 발명에 따른 바디워시 조성물의 제조방법은 복합추출물을 제조하는 단계를 포함한다. 상기 복합추출물을 제조하는 단계는, 이질풀잎, 구멍갈파래 및 천년초를 세척하고, 48-52℃의 온도에서 2-4시간 동안 건조하는 단계; 건조한 이질풀잎, 구멍갈파래 및 천년초를 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하는 단계; 상기 혼합분말 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 118-122℃의 온도에서 5-7시간 동안 1차 열수추출을 수행하는 단계; 1차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 1차 추출물을 제조하는 단계; 1차 열수추출 후 여과지로 여과한 다음 남은 고형물 8-12 중량부 및 정제수 88-92 중량부를 혼합하고, 여기에 토코페롤 0.8-1.2 중량부 및 [BMIM][BF4](1-butyl-3-methylimidazolium tetrafluoroborate)를 0.8-1.2 중량부를 첨가한 후 교반하면서 88-92℃의 온도에서 10-14시간 동안 2차 열수추출을 수행하는 단계; 2차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 2차 추출물을 제조하는 단계; 및 상기 1차 추출물 및 2차 추출물을 혼합하는 단계;를 포함한다.First, the method for producing a body wash composition according to the present invention includes preparing a complex extract. The step of preparing the complex extract includes washing the leaves of E. chinensis, Corolla, and Prickly pear, and drying them at a temperature of 48-52° C. for 2-4 hours; Preparing a mixed powder by grinding dried Chinese herbaceous leaves, Chinese apricots, and Chinese prickly pear and mixing them at a weight ratio of 1:1:1; Mixing 8-12 parts by weight of the mixed powder and 88-92 parts by weight of purified water and performing primary hot water extraction at a temperature of 118-122°C for 5-7 hours; After primary hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a primary extract; After the first hot water extraction and filtering with filter paper, 8-12 parts by weight of the remaining solids and 88-92 parts by weight of purified water were mixed, and 0.8-1.2 parts by weight of tocopherol and [BMIM][BF 4 ](1-butyl-3- Adding 0.8-1.2 parts by weight of methylimidazolium tetrafluoroborate) and performing secondary hot water extraction at a temperature of 88-92°C for 10-14 hours while stirring; After secondary hot water extraction, filtering through filter paper and then freeze-drying the filtrate to prepare a secondary extract; and mixing the primary extract and the secondary extract.
상기 복합추출물을 제조함에 있어서, 2단계의 열수추출을 적용하되, 1차 열수추출을 통해 추출액 제조와 더불어 전처리 과정을 거친 후, 2차 열수추출을 수행하되, 첨가제로 토코페롤과 이온성액체 중 [BMIM[BF4]를 동시 적용하여 추출성능을 높여 유효성분의 추출효율이 우수하다. 이에 따라 상기 복합추출물을 적용하는 경우 더욱 우수한 항산화 기능성 및 항염 기능성을 통해 안티에이징 효과가 향상된다.In preparing the complex extract, a two-stage hot water extraction is applied, and after a pretreatment process is performed along with the preparation of the extract through the first hot water extraction, a second hot water extraction is performed, and tocopherol and ionic liquid [ The extraction performance is improved by simultaneously applying BMIM[BF 4 ], resulting in excellent extraction efficiency of active ingredients. Accordingly, when the above complex extract is applied, the anti-aging effect is improved through superior antioxidant and anti-inflammatory functionality.
다음으로, 본 발명에 따른 바디워시 조성물의 제조방법은 난황유 0.1-0.3 중량부, 상기 복합추출물 3-7 중량부, 소듐C14-16올레핀설포네이트 4-5 중량부, 다이소듐코코암포다이아세테이트 3-5 중량부, 소듐클로라이드 2-4 중량부, 데실글루코사이드 2-4 중량부, 글리세린 0.9-1.1 중량부, 아크릴레이트코폴리머 0.09-0.11 중량부, 시트릭애씨드 0.09-0.11 중량부, 헥실렌글라이콜 0.09-0.11 중량부, C12-13알케스-9 0.09-0.11 중량부, 코코-베타인 0.09-0.11 중량부, 테트라데센 0.09-0.11 중량부, 하이드록시아세토페논 0.4-0.6 중량부, 헥사데센 0.09-0.11 중량부, 스타이렌/아크릴레이트코폴리머 0.4-0.6 중량부, 다이프로필렌글라이콜 0.2-0.4 중량부, 에틸헥실글리세린 0.1-0.3 중량부, 1,2-헥산다이올 0.1-0.3 중량부, 다이소듐이디티에이 0.04-0.06 중량부, 소듐시트레이트 0.00009-0.00011 중량부, 토코페롤 0.00009-0.00011 중량부, 레몬껍질오일 0.09-0.11 중량부, 분비나무오일 0.09-0.11 중량부, 라임전초오일 0.09-0.11 중량부, 시트로넬라오일 0.09-0.11 중량부, 리모넨 0.3-0.5 중량부, 제라니올 0.3-0.5 중량부, 시트로넬올 0.3-0.5 중량부 및 정제수 80.2497-80.2499 중량부를 혼합하는 단계를 포함한다.Next, the method for producing the body wash composition according to the present invention is 0.1-0.3 parts by weight of egg yolk oil, 3-7 parts by weight of the complex extract, 4-5 parts by weight of sodium C14-16 olefin sulfonate, and 3 parts by weight of disodium cocoamphodiacetate. -5 parts by weight, sodium chloride 2-4 parts by weight, decyl glucoside 2-4 parts by weight, glycerin 0.9-1.1 parts by weight, acrylate copolymer 0.09-0.11 parts by weight, citric acid 0.09-0.11 parts by weight, hexylene glycol Lycol 0.09-0.11 parts by weight, C12-13 Alkes-9 0.09-0.11 parts by weight, Coco-Betaine 0.09-0.11 parts by weight, Tetradecene 0.09-0.11 parts by weight, Hydroxyacetophenone 0.4-0.6 parts by weight, Hexadecyl Decene 0.09-0.11 parts by weight, styrene/acrylate copolymer 0.4-0.6 parts by weight, dipropylene glycol 0.2-0.4 parts by weight, ethylhexylglycerin 0.1-0.3 parts by weight, 1,2-hexanediol 0.1-0.3 Parts by weight, Disodium EDTA 0.04-0.06 parts by weight, Sodium citrate 0.00009-0.00011 parts by weight, Tocopherol 0.00009-0.00011 parts by weight, Lemon peel oil 0.09-0.11 parts by weight, Secretion tree oil 0.09-0.11 parts by weight, Lime whole plant Mixing 0.09-0.11 parts by weight of oil, 0.09-0.11 parts by weight of citronella oil, 0.3-0.5 parts by weight of limonene, 0.3-0.5 parts by weight of geraniol, 0.3-0.5 parts by weight of citronellol, and 80.2497-80.2499 parts by weight of purified water. Includes steps.
이하, 본 발명을 하기의 실시예에 의해 보다 상세하게 설명한다.Hereinafter, the present invention will be explained in more detail by the following examples.
단, 하기 실시예는 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following examples only illustrate the content of the present invention and the scope of the invention is not limited by the examples and experimental examples.
<제조예 1> 복합추출물의 제조-1<Preparation Example 1> Preparation of complex extract-1
이질풀잎, 구멍갈파래 및 천년초를 세척하고, 50℃의 온도에서 3시간 동안 건조한 후, 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하였다. 상기 혼합분말 10 중량부 및 정제수 90 중량부를 혼합하고, 120℃의 온도에서 6시간 동안 1차 열수추출을 수행하였다.The mixed powder was prepared by washing the leaves of dysentery, dried apricots, and prickly pear, dried at a temperature of 50°C for 3 hours, pulverized, and mixed at a weight ratio of 1:1:1. 10 parts by weight of the mixed powder and 90 parts by weight of purified water were mixed, and primary hot water extraction was performed at a temperature of 120°C for 6 hours.
1차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 1차 추출물을 제조하였다. After the first hot water extraction, it was filtered through filter paper and the filtrate was freeze-dried to prepare the first extract.
남은 고형물 10 중량부 및 정제수 90 중량부를 혼합하고, 여기에 토코페롤 1 중량부 및 [BMIM][BF4](1-butyl-3-methylimidazolium tetrafluoroborate)를 1 중량부를 첨가한 후 교반하면서 90℃의 온도에서 12시간 동안 2차 열수추출을 수행하였다.Mix 10 parts by weight of the remaining solids and 90 parts by weight of purified water, add 1 part by weight of tocopherol and 1 part by weight of [BMIM][BF 4 ](1-butyl-3-methylimidazolium tetrafluoroborate), and stir at a temperature of 90°C. A second hot water extraction was performed for 12 hours.
2차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 2차 추출물을 제조하였다.After secondary hot water extraction, it was filtered through filter paper and the filtrate was freeze-dried to prepare a secondary extract.
상기 1차 추출물 및 2차 추출물을 혼합하여 복합추출물을 제조하였다.A composite extract was prepared by mixing the primary and secondary extracts.
<제조예 2> 복합추출물의 제조-2<Preparation Example 2> Preparation of complex extract-2
이질풀잎, 구멍갈파래 및 천년초를 세척하고, 50℃의 온도에서 3시간 동안 건조한 후, 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하였다. 상기 혼합분말 10 중량부 및 정제수 90 중량부를 혼합하고, 120℃의 온도에서 6시간 동안 1차 열수추출을 수행하였다.The mixed powder was prepared by washing the leaves of dysentery, dried apricots, and prickly pear, dried at a temperature of 50°C for 3 hours, pulverized, and mixed at a weight ratio of 1:1:1. 10 parts by weight of the mixed powder and 90 parts by weight of purified water were mixed, and primary hot water extraction was performed at a temperature of 120°C for 6 hours.
1차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 1차 추출물을 제조하였다. After the first hot water extraction, it was filtered through filter paper and the filtrate was freeze-dried to prepare the first extract.
남은 고형물 10 중량부 및 정제수 90 중량부를 혼합하고, 90℃의 온도에서 12시간 동안 2차 열수추출을 수행하였다.10 parts by weight of the remaining solids and 90 parts by weight of purified water were mixed, and secondary hot water extraction was performed at a temperature of 90°C for 12 hours.
2차 열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 2차 추출물을 제조하였다.After secondary hot water extraction, it was filtered through filter paper and the filtrate was freeze-dried to prepare a secondary extract.
상기 1차 추출물 및 2차 추출물을 혼합하여 복합추출물을 제조하였다.A composite extract was prepared by mixing the primary and secondary extracts.
<제조예 3> 복합추출물의 제조-3<Preparation Example 3> Preparation of complex extract-3
이질풀잎, 구멍갈파래 및 천년초를 세척하고, 50℃의 온도에서 3시간 동안 건조한 후, 분쇄하고, 1:1:1의 중량비율로 혼합하여 혼합분말을 제조하였다. 상기 혼합분말 10 중량부 및 정제수 90 중량부를 혼합하고, 120℃의 온도에서 6시간 동안 열수추출을 수행하였다.The mixed powder was prepared by washing the leaves of dysentery, dried apricots, and prickly pear, dried at a temperature of 50°C for 3 hours, pulverized, and mixed at a weight ratio of 1:1:1. 10 parts by weight of the mixed powder and 90 parts by weight of purified water were mixed, and hot water extraction was performed at a temperature of 120°C for 6 hours.
열수추출 후, 여과지로 여과한 다음 그 여액을 동결건조하여 복합추출물을 제조하였다. After hot water extraction, it was filtered through filter paper and the filtrate was freeze-dried to prepare a composite extract.
<실시예 1> 바디워시 조성물의 제조-1<Example 1> Preparation of body wash composition-1
난황유 0.2 중량부, 소듐C14-16올레핀설포네이트 4.5 중량부, 다이소듐코코암포다이아세테이트 4 중량부, 소듐클로라이드 3 중량부, 데실글루코사이드 3 중량부, 글리세린 1 중량부, 아크릴레이트코폴리머 0.1 중량부, 시트릭애씨드 0.1 중량부, 헥실렌글라이콜 0.1 중량부, C12-13알케스-9 0.1 중량부, 코코-베타인 0.1 중량부, 테트라데센 0.1 중량부, 하이드록시아세토페논 0.5 중량부, 헥사데센 0.1 중량부, 스타이렌/아크릴레이트코폴리머 0.5 중량부, 다이프로필렌글라이콜 0.3 중량부, 에틸헥실글리세린 0.2 중량부, 1,2-헥산다이올 0.2 중량부, 다이소듐이디티에이 0.05 중량부, 소듐시트레이트 0.0001 중량부, 토코페롤 0.0001 중량부, 레몬껍질오일 0.1 중량부, 분비나무오일 0.1 중량부, 라임전초오일 0.1 중량부, 시트로넬라오일 0.1 중량부, 리모넨 0.4 중량부, 제라니올 0.4 중량부, 시트로넬올 0.4 중량부 및 정제수 80.2498 중량부를 혼합하여 바디워시 조성물을 제조하였다.Egg yolk oil 0.2 parts by weight, sodium C14-16 olefin sulfonate 4.5 parts by weight, disodium cocoamphodiacetate 4 parts by weight, sodium chloride 3 parts by weight, decyl glucoside 3 parts by weight, glycerin 1 part by weight, acrylate copolymer 0.1 parts by weight , 0.1 part by weight of citric acid, 0.1 part by weight of hexylene glycol, 0.1 part by weight of C12-13 Alkes-9, 0.1 part by weight of coco-betaine, 0.1 part by weight of tetradecene, 0.5 part by weight of hydroxyacetophenone, 0.1 part by weight of hexadecene, 0.5 part by weight of styrene/acrylate copolymer, 0.3 part by weight of dipropylene glycol, 0.2 part by weight of ethylhexylglycerin, 0.2 part by weight of 1,2-hexanediol, 0.05 part by weight of disodium EDTA. Parts by weight, sodium citrate 0.0001 parts by weight, tocopherol 0.0001 parts by weight, lemon peel oil 0.1 parts by weight, secretion tree oil 0.1 parts by weight, lime whole plant oil 0.1 parts by weight, citronella oil 0.1 parts by weight, limonene 0.4 parts by weight, agent A body wash composition was prepared by mixing 0.4 parts by weight of raniol, 0.4 parts by weight of citronellol, and 80.2498 parts by weight of purified water.
<실시예 2> 바디워시 조성물의 제조-2<Example 2> Preparation of body wash composition-2
난황유 0.2 중량부, 상기 제조예 1에서 제조한 복합추출물 5 중량부, 소듐C14-16올레핀설포네이트 4.5 중량부, 다이소듐코코암포다이아세테이트 4 중량부, 소듐클로라이드 3 중량부, 데실글루코사이드 3 중량부, 글리세린 1 중량부, 아크릴레이트코폴리머 0.1 중량부, 시트릭애씨드 0.1 중량부, 헥실렌글라이콜 0.1 중량부, C12-13알케스-9 0.1 중량부, 코코-베타인 0.1 중량부, 테트라데센 0.1 중량부, 하이드록시아세토페논 0.5 중량부, 헥사데센 0.1 중량부, 스타이렌/아크릴레이트코폴리머 0.5 중량부, 다이프로필렌글라이콜 0.3 중량부, 에틸헥실글리세린 0.2 중량부, 1,2-헥산다이올 0.2 중량부, 다이소듐이디티에이 0.05 중량부, 소듐시트레이트 0.0001 중량부, 토코페롤 0.0001 중량부, 레몬껍질오일 0.1 중량부, 분비나무오일 0.1 중량부, 라임전초오일 0.1 중량부, 시트로넬라오일 0.1 중량부, 리모넨 0.4 중량부, 제라니올 0.4 중량부, 시트로넬올 0.4 중량부 및 정제수 80.2498 중량부를 혼합하여 바디워시 조성물을 제조하였다.0.2 parts by weight of egg yolk oil, 5 parts by weight of the complex extract prepared in Preparation Example 1, 4.5 parts by weight of sodium C14-16 olefin sulfonate, 4 parts by weight of disodium cocoamphodiacetate, 3 parts by weight of sodium chloride, 3 parts by weight of decyl glucoside , 1 part by weight of glycerin, 0.1 part by weight of acrylate copolymer, 0.1 part by weight of citric acid, 0.1 part by weight of hexylene glycol, 0.1 part by weight of C12-13 Alkes-9, 0.1 part by weight of coco-betaine, tetra 0.1 part by weight of decene, 0.5 part by weight of hydroxyacetophenone, 0.1 part by weight of hexadecene, 0.5 part by weight of styrene/acrylate copolymer, 0.3 part by weight of dipropylene glycol, 0.2 part by weight of ethylhexylglycerin, 1,2- Hexanediol 0.2 parts by weight, Disodium EDTA 0.05 parts by weight, Sodium citrate 0.0001 parts by weight, Tocopherol 0.0001 parts by weight, Lemon peel oil 0.1 parts by weight, Secretion tree oil 0.1 parts by weight, Lime herb oil 0.1 parts by weight, sheet A body wash composition was prepared by mixing 0.1 parts by weight of ronella oil, 0.4 parts by weight of limonene, 0.4 parts by weight of geraniol, 0.4 parts by weight of citronellol, and 80.2498 parts by weight of purified water.
<실시예 3> 바디워시 조성물의 제조-3<Example 3> Preparation of body wash composition-3
난황유 0.2 중량부, 상기 제조예 2에서 제조한 복합추출물 5 중량부, 소듐C14-16올레핀설포네이트 4.5 중량부, 다이소듐코코암포다이아세테이트 4 중량부, 소듐클로라이드 3 중량부, 데실글루코사이드 3 중량부, 글리세린 1 중량부, 아크릴레이트코폴리머 0.1 중량부, 시트릭애씨드 0.1 중량부, 헥실렌글라이콜 0.1 중량부, C12-13알케스-9 0.1 중량부, 코코-베타인 0.1 중량부, 테트라데센 0.1 중량부, 하이드록시아세토페논 0.5 중량부, 헥사데센 0.1 중량부, 스타이렌/아크릴레이트코폴리머 0.5 중량부, 다이프로필렌글라이콜 0.3 중량부, 에틸헥실글리세린 0.2 중량부, 1,2-헥산다이올 0.2 중량부, 다이소듐이디티에이 0.05 중량부, 소듐시트레이트 0.0001 중량부, 토코페롤 0.0001 중량부, 레몬껍질오일 0.1 중량부, 분비나무오일 0.1 중량부, 라임전초오일 0.1 중량부, 시트로넬라오일 0.1 중량부, 리모넨 0.4 중량부, 제라니올 0.4 중량부, 시트로넬올 0.4 중량부 및 정제수 80.2498 중량부를 혼합하여 바디워시 조성물을 제조하였다.0.2 parts by weight of egg yolk oil, 5 parts by weight of the complex extract prepared in Preparation Example 2, 4.5 parts by weight of sodium C14-16 olefin sulfonate, 4 parts by weight of disodium cocoamphodiacetate, 3 parts by weight of sodium chloride, 3 parts by weight of decyl glucoside , 1 part by weight of glycerin, 0.1 part by weight of acrylate copolymer, 0.1 part by weight of citric acid, 0.1 part by weight of hexylene glycol, 0.1 part by weight of C12-13 Alkes-9, 0.1 part by weight of coco-betaine, tetra 0.1 part by weight of decene, 0.5 part by weight of hydroxyacetophenone, 0.1 part by weight of hexadecene, 0.5 part by weight of styrene/acrylate copolymer, 0.3 part by weight of dipropylene glycol, 0.2 part by weight of ethylhexylglycerin, 1,2- Hexanediol 0.2 parts by weight, Disodium EDTA 0.05 parts by weight, Sodium citrate 0.0001 parts by weight, Tocopherol 0.0001 parts by weight, Lemon peel oil 0.1 parts by weight, Secretion tree oil 0.1 parts by weight, Lime herb oil 0.1 parts by weight, sheet A body wash composition was prepared by mixing 0.1 parts by weight of ronella oil, 0.4 parts by weight of limonene, 0.4 parts by weight of geraniol, 0.4 parts by weight of citronellol, and 80.2498 parts by weight of purified water.
<실시예 4> 바디워시 조성물의 제조-4<Example 4> Preparation of body wash composition-4
난황유 0.2 중량부, 상기 제조예 1에서 제조한 복합추출물 5 중량부, 소듐C14-16올레핀설포네이트 4.5 중량부, 다이소듐코코암포다이아세테이트 4 중량부, 소듐클로라이드 3 중량부, 데실글루코사이드 3 중량부, 글리세린 1 중량부, 아크릴레이트코폴리머 0.1 중량부, 시트릭애씨드 0.1 중량부, 헥실렌글라이콜 0.1 중량부, C12-13알케스-9 0.1 중량부, 코코-베타인 0.1 중량부, 테트라데센 0.1 중량부, 하이드록시아세토페논 0.5 중량부, 헥사데센 0.1 중량부, 스타이렌/아크릴레이트코폴리머 0.5 중량부, 다이프로필렌글라이콜 0.3 중량부, 에틸헥실글리세린 0.2 중량부, 1,2-헥산다이올 0.2 중량부, 다이소듐이디티에이 0.05 중량부, 소듐시트레이트 0.0001 중량부, 토코페롤 0.0001 중량부, 레몬껍질오일 0.1 중량부, 분비나무오일 0.1 중량부, 라임전초오일 0.1 중량부, 시트로넬라오일 0.1 중량부, 리모넨 0.4 중량부, 제라니올 0.4 중량부, 시트로넬올 0.4 중량부 및 정제수 80.2498 중량부를 혼합하여 바디워시 조성물을 제조하였다.0.2 parts by weight of egg yolk oil, 5 parts by weight of the complex extract prepared in Preparation Example 1, 4.5 parts by weight of sodium C14-16 olefin sulfonate, 4 parts by weight of disodium cocoamphodiacetate, 3 parts by weight of sodium chloride, 3 parts by weight of decyl glucoside , 1 part by weight of glycerin, 0.1 part by weight of acrylate copolymer, 0.1 part by weight of citric acid, 0.1 part by weight of hexylene glycol, 0.1 part by weight of C12-13 Alkes-9, 0.1 part by weight of coco-betaine, tetra 0.1 part by weight of decene, 0.5 part by weight of hydroxyacetophenone, 0.1 part by weight of hexadecene, 0.5 part by weight of styrene/acrylate copolymer, 0.3 part by weight of dipropylene glycol, 0.2 part by weight of ethylhexylglycerin, 1,2- Hexanediol 0.2 parts by weight, Disodium EDTA 0.05 parts by weight, Sodium citrate 0.0001 parts by weight, Tocopherol 0.0001 parts by weight, Lemon peel oil 0.1 parts by weight, Secretion tree oil 0.1 parts by weight, Lime herb oil 0.1 parts by weight, sheet A body wash composition was prepared by mixing 0.1 parts by weight of ronella oil, 0.4 parts by weight of limonene, 0.4 parts by weight of geraniol, 0.4 parts by weight of citronellol, and 80.2498 parts by weight of purified water.
<실험예 1> 항산화 기능성, 항염 기능성 및 안티에이징 효과 분석<Experimental Example 1> Analysis of antioxidant functionality, anti-inflammatory functionality, and anti-aging effect
1. 항산화 기능성1. Antioxidant functionality
상기 제조예 1-3에서 제조한 복합추출물을 시료로 하여 항산화력을 DPPH(2,2-Diphenyl-1-picryl-hydrazyl)라디칼 소거 활성으로 측정하였다. DPPH 라디칼 소거능은 Mensor 등의 방법을 참고하였다. 80 ㎕의 0.2 mM DPPH 에탄올 용액을 각 시료에 20 ㎕ 가한 후 1분간 교반한 후 25℃ 인큐베이터에서 10분간 반응시켜 ELISA reader를 사용하여 517nm에서 흡광도를 측정하였다. DPPH 라디칼 소거활성은 하기 식 1에 따라 백분율로 나타내었으며 그 결과를 하기 표 1에 나타내었다.Using the composite extract prepared in Preparation Example 1-3 as a sample, the antioxidant power was measured by DPPH (2,2-Diphenyl-1-picryl-hydrazyl) radical scavenging activity. DPPH radical scavenging ability was determined by referring to the method of Mensor et al. 80 ㎕ of 0.2mM DPPH ethanol solution was added to each sample, stirred for 1 minute, reacted in a 25°C incubator for 10 minutes, and absorbance was measured at 517 nm using an ELISA reader. DPPH radical scavenging activity was expressed as a percentage according to Equation 1 below, and the results are shown in Table 1 below.
<식 1><Equation 1>
DPPH 라디칼 소거활성(%) = {(1-시료 첨가시 흡광도)/대조구 흡광도}×100DPPH radical scavenging activity (%) = {(1-absorbance when adding sample)/absorbance of control}×100
상기 표 1에서 나타낸 바와 같이, 본 발명에 따른 복합추출물은 높은 DPPH 라디칼 소거활성 수치값이 측정되었으며, 우수한 항산화 기능성을 가짐을 확인할 수 있다.As shown in Table 1, the complex extract according to the present invention was measured to have a high DPPH radical scavenging activity value, and it can be confirmed that it has excellent antioxidant functionality.
2. 항염 기능성2. Anti-inflammatory functionality
상기 제조예 1-3에서 제조한 복합추출물을 시료로 하여 NO(Nitric Oxide) 생성 억제에 대한 효과를 확인하였다. 일반적인 NO의 형성은 박테리아를 죽이거나 종양을 제거시키는 중요한 역할을 하지만, 염증상태에서 iNOS에 의해 생성된 NO는 혈관 투과성, 부종 등의 염증반응을 촉진시킬 뿐만 아니라 염증매개체의 생합성을 촉진하여 염증을 심화시키는 것으로 알려져 있다. Raw 264.7 세포를 10% 륜가 첨가된 DMEM 배지를 이용하여 5×105 cell/well로 조절한 후 24 well plate에 접종하고, 시료를 처리하고 30분 배양 후 LPS(Lipopolysaccharide, 1㎍/㎖)를 첨가하여 24시간 배양하였다. 생성된 NO의 양은 NO 검출키트(iNtRON)를 이용한 측정값을 하기 식 2에 의해 산출하였으며 NO 생성 억제율 결과는 하기 표 2에 나타내었다.The composite extract prepared in Preparation Example 1-3 was used as a sample to confirm the effect on inhibiting NO (Nitric Oxide) production. Normal formation of NO plays an important role in killing bacteria or removing tumors, but in inflammatory conditions, NO produced by iNOS not only promotes inflammatory reactions such as vascular permeability and edema, but also promotes the biosynthesis of inflammatory mediators to reduce inflammation. It is known to worsen. Raw 264.7 cells were adjusted to 5 Added and cultured for 24 hours. The amount of NO produced was measured using a NO detection kit (iNtRON) and calculated according to Equation 2 below, and the NO production inhibition rate results are shown in Table 2 below.
<식 2><Equation 2>
NO 생성 억제율(%) = (대조군의 NO양-추출물의 NO양)/대조군의 NO양NO production inhibition rate (%) = (NO amount of control group - NO amount of extract)/NO amount of control group
상기 표 2에서 나타낸 바와 같이, 본 발명에 따른 복합추출물은 매우 높은 NO 생성 억제율을 나타내었으며, 우수한 항염 효과가 나타내는 것을 확인할 수 있다.As shown in Table 2 above, the complex extract according to the present invention showed a very high NO production inhibition rate and showed excellent anti-inflammatory effects.
3. 안티에이징 효과3. Anti-aging effect
상기 제조예 1-3에서 제조한 복합추출물을 시료로 하여 과산화수소 처리로 인한 섬유아세포의 노화 억제 효과를 확인하였다. 인간의 정상 섬유아세포(Human normal fibroblast, ATCC)를 DMEM 배지가 들어 있는 6-웰 마이크로 플레이트에 약 1×105개의 세포가 되도록 접종시키고, 5% 농도의 CO2 배양기에서 37℃, 24시간 동안 배양하였다. 그 후, 제조예 1-3에서 제조한 복합추출물과 산화스트레스를 유도할 수 있는 과산화수소(H2O2 300 μM)를 함께 배양배지에 녹인 뒤 처리하였다. 72시간 후 세포 배양 상등액을 제거하고, 트립신-EDTA를 처리하여 세포를 떼어낸 다음, Dojindo사의 SPiDER-ßGal으로 세포를 15분동안 형광염색하고, 유동계수기(flow cytometry, FACS Calibur, Becton Dickinson, San Jose, CA)로 세포를 계수하였다. 노화 관련 β-갈락토시다아제 활성을 나타내는 세포의 비율을 확인하여 세포노화의 변화를 관찰하였다. 이로부터 나온 결과값은 대조군을 100% 기준으로 하여 환산하였으며, 그 결과를 하기 표 3에 나타내었다. (-: 효과없음, +: 약한 효과, ++: 중간정도의 효과, +++: 강한 효과, ++++: 매우 강한 효과)The composite extract prepared in Preparation Example 1-3 was used as a sample to confirm the effect of inhibiting aging of fibroblasts due to hydrogen peroxide treatment. Human normal fibroblast (ATCC) cells were inoculated into a 6-well microplate containing DMEM medium at approximately 1×10 5 cells and incubated in a 5% CO 2 incubator at 37°C for 24 hours. Cultured. Afterwards, the complex extract prepared in Preparation Example 1-3 and hydrogen peroxide (H 2 O 2 300 μM), which can induce oxidative stress, were dissolved together in the culture medium and treated. After 72 hours, the cell culture supernatant was removed, the cells were detached by treatment with trypsin-EDTA, and the cells were fluorescently stained with Dojindo's SPiDER-ßGal for 15 minutes and flow cytometry (FACS Calibur, Becton Dickinson, San Francisco). Jose, CA), and cells were counted. Changes in cellular aging were observed by confirming the proportion of cells showing aging-related β-galactosidase activity. The resulting values were converted based on 100% of the control group, and the results are shown in Table 3 below. (-: no effect, +: weak effect, ++: medium effect, +++: strong effect, ++++: very strong effect)
노화억제 정도Fibroblasts due to hydrogen peroxide treatment
Degree of anti-aging
상기 표 3에서 나타낸 바와 같이, 본 발명에 따른 복합추출물은 매우 높은 과산화수소 처리로 인한 섬유아세포 노화억제 정도를 나타내었다.As shown in Table 3, the composite extract according to the present invention showed a very high degree of inhibition of fibroblast aging due to hydrogen peroxide treatment.
이와 같이, 항산화 기능성, 항염 기능성을 확보하였으며, 안티에이징 효과가 뛰어남을 확인할 수 있었다.In this way, antioxidant functionality and anti-inflammatory functionality were secured, and it was confirmed that the anti-aging effect was excellent.
<실험예 2> 피부 보습 기능성 분석<Experimental Example 2> Analysis of skin moisturizing functionality
상기 실시예 1-4에서 제조한 바디워시 조성물을 시료로 하여 피부 보습 기능성 시험을 수행하였다. 피부가 민감한 나이 30-40세로 구성된 성인남녀 40명(각각 20명씩)을 대상으로 무작위로 성인남녀 5명씩 나누어 4개의 그룹으로 구분한 후, 상기 실시예 1-4에서 제조한 바디워시 조성물로 각각 샤워를 시킨 직후 피부 보습 기능성을 확인하였다. 피부 보습 기능성은 시험시작 30분전부터 항온항습조건(20-22℃, 상대습도 40-60%)의 실내에서 대기한 지원자의 피부수분량 측정기(Corneometer, CM825)를 이용하여 보습력을 측정하였다. 측정된 capacitance value는 0-120 사이의 arbitrary capacitance units(A.U.)로 표시되며, 그 결과를 하기 표 4에 나타내었다.A skin moisturizing functionality test was performed using the body wash composition prepared in Examples 1-4 as a sample. 40 adult men and women (20 each) aged 30-40 years with sensitive skin were randomly divided into 4 groups of 5 adults each, and each was treated with the body wash composition prepared in Examples 1-4 above. The skin moisturizing functionality was confirmed immediately after taking a shower. Skin moisturizing functionality was measured using a skin moisture meter (Corneometer, CM825) of volunteers who waited indoors under constant temperature and humidity conditions (20-22°C, relative humidity 40-60%) 30 minutes before the start of the test. The measured capacitance value is expressed as arbitrary capacitance units (A.U.) between 0 and 120, and the results are shown in Table 4 below.
상기 표 4에서 나타낸 바와 같이, 본 발명에 따른 바디워시 조성물은 매우 우수한 피부 보습 기능성을 나타냄을 확인할 수 있었다.As shown in Table 4, it was confirmed that the body wash composition according to the present invention exhibited very excellent skin moisturizing functionality.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240001695A KR102648658B1 (en) | 2024-01-04 | 2024-01-04 | Body wash using egg yolk oil with anti-aging effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240001695A KR102648658B1 (en) | 2024-01-04 | 2024-01-04 | Body wash using egg yolk oil with anti-aging effect |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102648658B1 true KR102648658B1 (en) | 2024-03-19 |
Family
ID=90483049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020240001695A KR102648658B1 (en) | 2024-01-04 | 2024-01-04 | Body wash using egg yolk oil with anti-aging effect |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102648658B1 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140074475A (en) * | 2012-12-10 | 2014-06-18 | 김미량 | Cosmetic composition |
KR101496624B1 (en) | 2014-12-02 | 2015-02-26 | 김윤 | Cosmetic soap composition for exfoliating containing solid citron by-product and manufacturing method of cosmetic soap using the same |
KR20160050527A (en) * | 2014-10-30 | 2016-05-11 | 재단법인 전남생물산업진흥원 | Composition of cosmetics for anti-wrinkle containing Ulva pertusa Kjellman extracts |
KR101958279B1 (en) * | 2018-05-29 | 2019-07-02 | 주식회사 에프지뷰티 | A cosmetic composition for skin moisturizing comprising opuntia humifusa extract |
KR102268243B1 (en) * | 2020-08-19 | 2021-06-24 | 주식회사 제이에스무역 | A hair care composition comprising egg yolk oil |
KR102300732B1 (en) * | 2020-11-11 | 2021-09-14 | 주식회사 제이에스무역 | A composition for anti-oxidating, whitening, anti-wrinkle or anti-inflammation comprising egg yolk oil and korean mint stem cell |
KR20220145932A (en) * | 2021-04-19 | 2022-10-31 | 농업회사법인 주식회사에코드림팜 | Manufacturing method of egg yolk oil, egg yolk oil manufactured thereby, and products containing the same |
KR20220168214A (en) * | 2021-06-15 | 2022-12-23 | 전라남도 | Cosmetic composition for body cleanser containing turmeric |
-
2024
- 2024-01-04 KR KR1020240001695A patent/KR102648658B1/en active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140074475A (en) * | 2012-12-10 | 2014-06-18 | 김미량 | Cosmetic composition |
KR20160050527A (en) * | 2014-10-30 | 2016-05-11 | 재단법인 전남생물산업진흥원 | Composition of cosmetics for anti-wrinkle containing Ulva pertusa Kjellman extracts |
KR101496624B1 (en) | 2014-12-02 | 2015-02-26 | 김윤 | Cosmetic soap composition for exfoliating containing solid citron by-product and manufacturing method of cosmetic soap using the same |
KR101958279B1 (en) * | 2018-05-29 | 2019-07-02 | 주식회사 에프지뷰티 | A cosmetic composition for skin moisturizing comprising opuntia humifusa extract |
KR102268243B1 (en) * | 2020-08-19 | 2021-06-24 | 주식회사 제이에스무역 | A hair care composition comprising egg yolk oil |
KR102300732B1 (en) * | 2020-11-11 | 2021-09-14 | 주식회사 제이에스무역 | A composition for anti-oxidating, whitening, anti-wrinkle or anti-inflammation comprising egg yolk oil and korean mint stem cell |
KR20220145932A (en) * | 2021-04-19 | 2022-10-31 | 농업회사법인 주식회사에코드림팜 | Manufacturing method of egg yolk oil, egg yolk oil manufactured thereby, and products containing the same |
KR20220168214A (en) * | 2021-06-15 | 2022-12-23 | 전라남도 | Cosmetic composition for body cleanser containing turmeric |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102038650B1 (en) | Composite of Natural soap for skin cure and Method of manufacturing thereof | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
KR102006708B1 (en) | Soap composition using wood-cultivated ginseng and soap comprising the same | |
KR101189989B1 (en) | Cosmetic composition containing as available ingredient the extracts of Equisetum arvense L. | |
KR101895412B1 (en) | A functional cosmetic composition for skin whitening comprising natural complex extract | |
CN111658582A (en) | Anti-aging cosmetic composition comprising mixed extract of unripe fruits | |
KR102226774B1 (en) | Detergent comprising the extract of astragalus membranaceus, polydonati rhizoma and pine leaf, and the method of manufacturing thereof | |
KR20180057329A (en) | A fermented composition for improving atopic dermatitis contaning natural extract | |
KR102350749B1 (en) | Functional cosmetic composition with excellent skin anti-aging activity, skin moisturizing and skin soothing effect including fruit extract | |
KR102648658B1 (en) | Body wash using egg yolk oil with anti-aging effect | |
KR20190074663A (en) | Natural soap composition | |
KR101135340B1 (en) | Anti-oxidating cosmetic composition | |
CN103340818B (en) | Massage tea oil | |
KR101252548B1 (en) | A cosmetic composition containing as available ingredient the extracts of Pinus koraiensis | |
KR102303400B1 (en) | Preparation Methods of Fermentation Products Using JEJU Lava Seawater, JEJU Barley Yeast and Natural Plant and Cosmetic Compositions Having Thereof | |
KR102386118B1 (en) | Composition comprising Lespedeza plant extracts for skin volume augmentation | |
CN108542829A (en) | A kind of plant moisturizing suncream and preparation method thereof | |
KR20190061277A (en) | shampoo composition for prevent alopecia and growing of hair | |
KR20230081341A (en) | Shampoo for fine hair improvement with herbal extracts | |
KR20170137436A (en) | Composition for improving skin condition comprising herb extracts mixture | |
CN110613646A (en) | Facial cleansing bubble containing hemp extract and preparation method thereof | |
KR102630715B1 (en) | cosmetic composition for skin whitening and antiwrinkle | |
KR101687293B1 (en) | Cosmetic composition for improving wrinkle and atopic dermatitis and cosmetic comprising the complex composition | |
KR102648655B1 (en) | Shampoo for dogs using egg yolk oil | |
KR102638536B1 (en) | Skin soothing cosmetic composition containing 7 kinds of natural complexes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |